PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Deep Vein Thrombosis 10,952 Disease Drug Angiomax (Bivalirudin)- FDA 13 1 0.00 -0.96 0.08 0.63
Androgen Receptor 12,918 Target Target Sulfonylurea Receptor 2b 13 1 0.00 -0.96 0.08 0.63
Antithrombin 13,773 Target Target AMY1A 13 1 0.00 -0.96 0.08 0.62
Attention Deficit Hyperactivity Disorder 14,687 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.62
Hearing Loss 30,622 Disease Target Glutathione Peroxidase 6 13 2 0.00 -0.92 0.15 0.62
Sickle Cell 17,551 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.62
Aggression 20,035 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.62
Chronic Pain 21,087 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.61
Migraine 24,200 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.61
Calmodulin 25,240 Target Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.61
Angiotensin Converting Enzyme 31,674 Target Disease Nephropathy Diabetic 13 1 0.00 -0.96 0.08 0.60
Angiotensin Converting Enzyme 31,674 Target Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.60
Arthritis 128,324 Disease Drug Acitretin (Soriatane)- FDA 13 4 0.00 -0.83 0.31 0.60
Brain Injury 34,874 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.60
Diabetes 332,602 Disease Disease Nephropathy Diabetic 13 9 0.00 -0.55 0.69 0.60
Schizophrenia 77,034 Disease Target Tachykinin Receptor 1 13 2 0.00 -0.92 0.15 0.60
Renin 43,456 Target Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.60
Renin 43,456 Target Target AMY1A 13 1 0.00 -0.96 0.08 0.60
Seizure 44,685 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.60
Analgesia 44,857 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.60
Anxiety 113,510 Disease Target Tachykinin Receptor 1 13 2 0.00 -0.92 0.15 0.59
Stroke 146,992 Disease Drug Angiomax (Bivalirudin)- FDA 13 2 0.00 -0.92 0.15 0.59
Shock 134,031 Disease Target Glutathione Peroxidase 6 13 1 0.00 -0.96 0.08 0.57
Obesity 138,233 Disease Drug Alpha (Prolastin)- FDA 13 1 0.00 -0.96 0.08 0.57
Cholesterol 182,390 Disease Target Glutathione Peroxidase 6 13 1 0.00 -0.96 0.08 0.57
Pain 409,851 Disease Target Tachykinin Receptor 1 13 2 0.00 -0.92 0.15 0.56
Depression 220,092 Disease Drug Acitretin (Soriatane)- FDA 13 1 0.00 -0.96 0.08 0.56
Depression 220,092 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.56
Carcinoma 433,099 Disease Drug Alpha (Prolastin)- FDA 13 1 0.00 -0.96 0.08 0.55
Carcinoma 433,099 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.55
Carcinoma 433,099 Disease Target AMY1A 13 1 0.00 -0.96 0.08 0.55
Infection 766,637 Disease Drug Acitretin (Soriatane)- FDA 13 1 0.00 -0.96 0.08 0.54
Infection 766,637 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.54
Infection 766,637 Disease Target Glutathione Peroxidase 6 13 1 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.53
Cancer 1,053,491 Disease Target Glutathione Peroxidase 6 13 1 0.00 -0.96 0.08 0.53
Cancer 1,053,491 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.53
CD22 1,591 Target Drug Arranon (Nelarabine)- FDA 12 1 0.01 -0.96 0.08 0.68
Neutropenia 25,934 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 4 0.01 -0.82 0.33 0.64
Chronic Lymphocytic Leukemia 11,642 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.63
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Leukemias 14,152 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.63
Brain Tumors 16,749 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.62
Thrombocytopenia 35,805 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 2 0.00 -0.91 0.17 0.62
Leukemia 162,805 Disease Drug Arranon (Nelarabine)- FDA 12 9 0.01 -0.50 0.75 0.62
Nausea 42,627 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 2 0.00 -0.91 0.17 0.62
Hyperglycemia 28,168 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.61
Diarrhea 51,986 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.59
Seizures 66,465 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.59
Anemia 81,663 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.58
CD4 112,219 Target Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.58
CD4 112,219 Target Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.58
Shock 134,031 Disease Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.57
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
Tuberculosis 146,217 Disease Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.57
Hepatitis 163,842 Disease Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.57
Breast Cancer 173,695 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.57
Cholesterol 182,390 Disease Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.57
Cancer 1,053,491 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 3 0.00 -0.87 0.25 0.56
Infection 766,637 Disease Disease Leprosy Lepromatous 12 2 0.00 -0.91 0.17 0.55
Pain 409,851 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.55
Cancer 1,053,491 Disease Drug Arranon (Nelarabine)- FDA 12 2 0.00 -0.91 0.17 0.55
Infection 766,637 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.54
Atropine (Atropen)- FDA 11 Drug Drug Atropen (Atropine)- FDA 11 11 1.00 -0.08 1.00 1.00
Atropine (Atropine)- FDA 13 Drug Drug Atropine (Atropen)- FDA 11 11 0.92 -0.13 1.00 0.99
Atropine (Atropine)- FDA 13 Drug Drug Atropen (Atropine)- FDA 11 11 0.92 -0.13 1.00 0.99
Aralen (Chloroquine)- FDA 19 Drug Drug Atovaquone (Mepron)- FDA 11 3 0.21 -0.78 0.27 0.90
Akineton (Biperiden)- FDA 1 Drug Drug Atropine (Atropen)- FDA 11 1 0.30 -0.68 1.00 0.88
Akineton (Biperiden)- FDA 1 Drug Drug Atropen (Atropine)- FDA 11 1 0.30 -0.68 1.00 0.88
Atridox (Doxycycline Hyclate)- FDA 38 Drug Drug Atovaquone (Mepron)- FDA 11 2 0.10 -0.88 0.18 0.84
Acetaminophen (Tylenol)- FDA 69 Drug Drug Atropen (Atropine)- FDA 11 2 0.07 -0.89 0.18 0.82
Azithromycin (Zithromax)- FDA 36 Drug Drug Atovaquone (Mepron)- FDA 11 1 0.05 -0.94 0.09 0.82
Atosiban 274 Target Drug Atropine (Atropen)- FDA 11 1 0.02 -0.95 0.09 0.74
Atosiban 274 Target Drug Atropen (Atropine)- FDA 11 1 0.02 -0.95 0.09 0.74
Candidemia 1,512 Disease Drug Anidulafungin (Eraxis)- FDA 11 3 0.02 -0.85 0.27 0.72
Aspergillosis 9,759 Disease Drug Anidulafungin (Eraxis)- FDA 11 3 0.01 -0.85 0.27 0.66
Multiple Myeloma 24,594 Disease Disease Myeloma Multiple 11 7 0.01 -0.60 0.64 0.66
Glucocorticoid Receptor 10,306 Target Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.63
Poisoning 53,779 Disease Drug Atropine (Atropen)- FDA 11 5 0.01 -0.74 0.45 0.63
Poisoning 53,779 Disease Drug Atropen (Atropine)- FDA 11 5 0.01 -0.74 0.45 0.63
Epilepsy 71,172 Disease Disease Seizures Partial 11 6 0.01 -0.67 0.55 0.63
Seizure 44,685 Disease Disease Seizures Partial 11 3 0.00 -0.85 0.27 0.63
Pneumonia 81,521 Disease Drug Atovaquone (Mepron)- FDA 11 5 0.01 -0.74 0.45 0.62
CEA 17,022 Target Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.62
Malaria 56,215 Disease Drug Atovaquone (Mepron)- FDA 11 3 0.00 -0.85 0.27 0.62
Coma 24,208 Disease Drug Atropen (Atropine)- FDA 11 1 0.00 -0.95 0.09 0.61
CD34 24,598 Target Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.61
Neutropenia 25,934 Disease Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.61
Hyperglycemia 28,168 Disease Disease Seizures Partial 11 1 0.00 -0.95 0.09 0.61
Prostate Cancer 71,064 Disease Drug Aphrodyne (Yohimbine)- FDA 11 2 0.00 -0.90 0.18 0.60
Osteoarthritis 36,287 Disease Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.60
Nausea 42,627 Disease Drug Atropine (Atropen)- FDA 11 1 0.00 -0.95 0.09 0.60
Nausea 42,627 Disease Drug Atropen (Atropine)- FDA 11 1 0.00 -0.95 0.09 0.60
Seizure 44,685 Disease Target ADSF 11 1 0.00 -0.95 0.09 0.60
Anxiety 113,510 Disease Drug Aphrodyne (Yohimbine)- FDA 11 2 0.00 -0.90 0.18 0.59
Sepsis 64,798 Disease Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.59
Influenza 67,933 Disease Drug Kaempferol 7-O-Beta-D-Glucopyranoside 11 1 0.00 -0.95 0.09 0.59
Obesity 138,233 Disease Target ADSF 11 2 0.00 -0.90 0.18 0.59
Diabetes 332,602 Disease Target ADSF 11 3 0.00 -0.85 0.27 0.58
Fracture 111,575 Disease Target ADSF 11 1 0.00 -0.95 0.09 0.58